Amazon, Microsoft Escape Texas Patent Fight That Snags Instagram – Bloomberg Law
Amazon, Microsoft Escape Texas Patent Fight That Snags Instagram Bloomberg Law
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Pharmaceuticals Under Capitalism: A Case Study of Gilead’s Patent Extension Strategy
The recent example of Gilead shows how the pharmaceutical industry uses patent law to stifle medical progress and hurt the public.
-
In: PATENT NEWS
Drug Patents Are Stifling Progress and Making us Sicker – Left Voice
Drug Patents Are Stifling Progress and Making us Sicker Left Voice
-
In: PATENT NEWS
Police seize $650K in counterfeit merchandise from Arlington warehouse, officials say
… seized three separate shipments intended for Dia that contained “items that violated intellectual property law,” according to the affidavit.
-
In: PATENT NEWS
Corporate Failure Is a Valuable Asset That’s Hard to Protect – The Washington Post
A recent article in Business Law Today calls attention to something less tangible still — the … and perhaps refer to patent or other protection.
-
In: PATENT NEWS
Big Tech Is Abusing the U.S. Patent System. Time for Congress To Step In | Opinion – Newsweek
Big Tech Is Abusing the U.S. Patent System. Time for Congress To Step In | Opinion Newsweek
-
In: PATENT NEWS
Georgia’s GOP governor can’t pardon Trump — so Fox News guest wants Republicans to …
“Under the Georgia law, there is a statute that limits the Republican governor’s ability to pardon, and I think that the legislature in Georgia needs …
-
In: PATENT NEWS
Signal: The Coca-Cola Co., PepsiCo patent applications fall – just-drinks.com
Signal: The Coca-Cola Co., PepsiCo patent applications fall just-drinks.com
-
In: PATENT NEWS
Mudflap Patent Infringement Verdict Affirmed by Federal Circuit – Bloomberg Law
Mudflap Patent Infringement Verdict Affirmed by Federal Circuit Bloomberg Law
-
In: PATENT NEWS
Fighting Back Against Fake (and Real) Sinosure Claims: A Primer – Harris Bricken
It often hires debt collectors and law firms to chase foreign companies for money supposedly owed to its insured Chinese manufacturers.